Skip to main content
SpringerLink
Log in

Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Five healthy fasting male subjects were each given single doses of intravenous ampicillin (471 mg), oral ampicillin tablets (495 mg), oral bacampicillin hydrochloride tablets (562 mg ampicillin equivalent), and oral pivampicillin hydrochloride capsules (491 mg ampicillin equivalent) in a crossover experiment. The resulting concentrations of ampicillin were determined in plasma and urine. The pharmacokinetic analysis was made according to a two-compartment open model. The total distribution volume of unbound ampicillin during the disposition phase was 0.247 ± 0.045 (sd) liter/kg, which is only slightly more than the extracellular fluid, suggesting that tissue binding and intracellular distribution of ampicillin are limited. The bioavailability of the esters bacampicillin (86 ± 11%) and pivampicillin (92± 18%) was significantly greater than that of ampicillin (62 ± 17%); however, the difference between the esters was not statistically significant. The absorption for all drugs given orally proceeded at a constant rate, suggesting zero-order release rates from the products. The absorption rate was highest for bacampicillin (0.89 ± 0.39% of dose absorbed per minute), followed by pivampicillin (0.64 ± 0.19) and ampicillin (0.58 ± 0.16). Bacampicillin also had the shortest lag time for the start of absorption (7.0 ± 0.9 min) under the present conditions. Thus, in comparison with ampicillin, the esters have a higher bioavailability, which, in fact, is close to the theoretically highest possible value by clearance concepts. The higher bioavailability in connection with higher absorption rates may be clinically important in ampicillin treatment by the oral route.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B. Jalling, A. S. Malmborg, A. Lindman, and L. O. Boréus. Evaluation of a micromethod for determination of antibiotic concentration in plasma.Eur. J. Clin. Pharmacol. 4:150–157 (1972).

    Article  CAS  PubMed  Google Scholar 

  2. D. C. Grove and W. A. Randall.Assay Methods of Antibiotics: A Laboratory Manual, Medical Encyclopedia, New York, 1955.

    Google Scholar 

  3. M. Gibaldi and D. Perrier.Pharmacokinetics, Dekker, New York (1975).

    Google Scholar 

  4. M. Ehrnebo. Pharmacokinetics, and distribution properties of pentobarbital in humans following oral and intravenous administration.J. Pharm. Sci. 63:1114–1118 (1974).

    Article  CAS  PubMed  Google Scholar 

  5. K. Diem and C. Leutner.Documenta Geigy—Scientific Tables, 7th ed., Ciba-Geigy, Basel, 1975, pp. 518, 555.

    Google Scholar 

  6. J. Ekstrand, M. Ehrnebo, and L. O. Boréus. Determination of fluoride bioavailability in man following intravenous and oral administration: The importance of renal clearance and urinary flow.Clin. Pharmacol. Ther. 23:329–337 (1978).

    CAS  PubMed  Google Scholar 

  7. J. C. K. Loo and S. Riegelman. New method for calculating the intrinsic absorption rate of drugs.J. Pharm. Sci. 57:918–928 (1968).

    Article  CAS  PubMed  Google Scholar 

  8. L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).

    Article  CAS  PubMed  Google Scholar 

  9. C. M. Metzler, G. L. Elfring, and A. J. McEwen. A package of computer programs for pharmacokinetic modeling.Biometrics 30: No. 3 (1974).

    Google Scholar 

  10. Z. Modr and K. Dvoracek. Pharmacokinetics of ampicillin and hetacillin.Rev. Czech. Med. 16:84–95 (1970).

    CAS  PubMed  Google Scholar 

  11. T. Bergan and B. Øydvin. Cross over study of pencillin pharmacokinetics after intravenous infusions.Chemotherapy 20:263–279 (1974).

    Article  CAS  PubMed  Google Scholar 

  12. P. Bolme, B. Dahlström, N. Å. Diding, O. Flink, and L. Paalzow. Ampicillin: Comparison of bioavailability and pharmacokinetics after oral and intravenous administration of three brands.Eur. J. Clin. Pharmacol. 10:237–243 (1976).

    Article  CAS  Google Scholar 

  13. A. Philipson. Pharmacokinetics of ampicillin during pregnancy.J. Infect. Dis. 136:370–376 (1977).

    Article  CAS  PubMed  Google Scholar 

  14. T. Bergan. Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin.Antimicob. Agents Chemother. 13:971–974 (1978).

    Article  CAS  Google Scholar 

  15. C. Simon, V. Malerczyk, G. Zieroff, K. Lehmann, and V. Thiesen. Blut-, Harn- und Gallespiegel von Ampicillin bei intravenöser Dauerinfusion.Arzneim. Forsch. 25:654–657 (1975).

    CAS  Google Scholar 

  16. W. J. Jusko and G. P. Lewis. Comparison of ampicillin and hetacillin pharmacokinetics in man.J. Pharm. Sci. 62:69–76 (1973).

    Article  CAS  PubMed  Google Scholar 

  17. P. R. Byron and R. E. Notari. Critical analysis of “flip-flop” phenomenon in two-compartment pharmacokinetic model.J. Pharm. Sci. 65:1140–1144 (1976).

    Article  CAS  PubMed  Google Scholar 

  18. J. C. K. Loo, E. L. Foltz, H. Wallick, and K. C. Kwan. Pharmacokinetics of pivampicillin and ampicillin in man.Clin. Pharmacol. Ther. 16:35–43 (1974).

    CAS  PubMed  Google Scholar 

  19. M. Ehrnebo. Distribution of ampicillin in human whole blood.J. Pharm. Pharmacol. 30:730–731 (1978).

    Article  CAS  PubMed  Google Scholar 

  20. T. C. Eickhoff, J. W. Kislak, and M. Finland. Sodium ampicillin: Absorption and excretion of intramuscular and intravenous doses in normal young men.Am. J. Med. Sci. 70:163–171 (1965).

    Article  Google Scholar 

  21. P. Naumann. Experimentelle und klinische Untersuchungen zur parenteralen Anwendung von Ampicillin.Deutsch. Med. Wochenschr. 90:1085–1092 (1965).

    Article  CAS  Google Scholar 

  22. B. Lund, J. P. Kampmann, F. Lindahl, and J. Mølholm Hansen. Pivampicillin and ampicillin in bile, portal and peripheral blood.Clin. Pharmacol. Ther. 19:587–591 (1976).

    CAS  PubMed  Google Scholar 

  23. N. O. Bodin. B. Ekström, U. Forsgren, L.-P. Jalar, L. Magni, C.-H. Ramsay, and B. Sjöberg. Bacampicillin: A new orally well-absorbed derivative of ampicillin.Antimicrob. Agents Chemother. 8:518–525 (1975).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Å. Swan. Gastroinestinal absorption and metabolism of two35S-labelled ampicillin esters.Eur. J. Clin. Pharmacol. 9:299–306 (1976).

    Article  Google Scholar 

  25. M. W. Kunst and H. Matie. Absorption of pivampicillin in postoperative patients,Antimicrob. Agents Chemother. 8:11–14 (1975).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. M. Rozencweig, M. Staquet, and J. Klastersky. Antibacterial activity and pharmaco-kinetics of bacampicillin and ampicillin.Clin. Pharmacol. Ther. 19:592–597 (1976).

    CAS  PubMed  Google Scholar 

  27. J. Sjövall, L. Magni, and T. Bergan. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin and amoxicillin.Antimicrob. Agents Chemother. 13:90–96 (1978).

    Article  PubMed Central  PubMed  Google Scholar 

  28. M. Rowland. Influence of route of administration on drug availability.J. Pharm. Sci. 61:70–74 (1972).

    Article  CAS  PubMed  Google Scholar 

  29. M. Cole, M. D. Kenig, and V. A. Hewitt. Metabolism of pencillins to penicilloic acids and 6-aminopenicillanic acid in man in its significance in assessing pencillin absorption.Antimicrob. Agents Chemother. 3:463–468 (1973).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. P. J. McNamara, W. A. Colburn, and M. Gibaldi. Absorption kinetics of hydroflumethiazide.J. Clin. Pharmacol. 18:190–193 (1978).

    Article  CAS  PubMed  Google Scholar 

  31. W. A. Colburn, A. R. DiSanto, and M. Gibaldi. Pharmacokinetics of erythromycin on repetitive dosing.J. Clin. Pharmacol. 17:592–600 (1977).

    Article  CAS  PubMed  Google Scholar 

  32. H. Ehrsson, S.-O., Nilsson, M. Ehrnebo, I. Wallin, and G. Wennersten. Effect of food on kinetics of 8-metoxsalen.Clin. Pharmacol. Ther. 25:167–171 (1979).

    CAS  PubMed  Google Scholar 

  33. E. R. Garrett, H. Roseboom, J. R. Green, and W. Schuermann. Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage form.Int. J. Clin. Pharmacol. Biopharm. 16:193–208 (1978).

    CAS  PubMed  Google Scholar 

  34. S. C. Penzotti and J. W. Poole. Transport mechanisms ofβ-lactam antibiotics across everted rat gut.J. Pharm. Sci. 63:1803–1806 (1974).

    Article  CAS  PubMed  Google Scholar 

  35. A. Tsuji, E. Nakashima, I. Kagami, N. Honjo, and T. Yamana. Effect of dose-concentration on the absorption of amoxiciliin and ampicillin from the rat intestine.J. Pharm. Pharmacol. 29:707–708 (1977).

    Article  CAS  PubMed  Google Scholar 

  36. K. Miyazaki, O. Ogino, M. Nakano, and T. Arita. Intestinal absorption mechanisms of ampicillin derivatives in rats. I. Intestinal absorption of ampicillin derivatives.Chem. Pharm. Bull. (Tokyo) 25:246–252 (1977).

    Article  CAS  Google Scholar 

  37. L. Magni, B. Sjöberg, J. Sjövall, and J. Wessman. Clinical pharmacological studies with bacampicillin. In J. D. Williams and A. M. Geddes (eds.),Chemotherapy, Vol. 5: Penicillins and Cephalosporins, Plenum Press, New York, 1976, pp. 109–114.

    Chapter  Google Scholar 

  38. F. Nordbring. Review of side-effects of aminopenicillins. Infection.7 (suppl. 5):503–506 (1979).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Karolinska Pharmacy, Karolinska Hospital, Fack, S-104 01, Stockholm 60, Sweden

    Mats Ehrnebo & Sten-Ove Nilsson

  2. Department of Clinical Pharmacology, Karolinska Hospital, Fack, S-104 01, Stockholm 60, Sweden

    Lars O. Boréus

Authors
  1. Mats Ehrnebo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sten-Ove Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars O. Boréus
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by the Swedish Medical Research Council, Project No. 522 (L. O. B.).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ehrnebo, M., Nilsson, SO. & Boréus, L.O. Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man. Journal of Pharmacokinetics and Biopharmaceutics 7, 429–451 (1979). https://doi.org/10.1007/BF01062386

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01062386

Key words

Search

Navigation